Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.50
Delayed Data
As of Feb 27
 -0.27 / -3.47%
Today’s Change
4.71
Today|||52-Week Range
9.62
0.00%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 12.50, with a high estimate of 13.00 and a low estimate of 12.00. The median estimate represents a +66.67% increase from the last price of 7.50.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Imprimis Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$3.1M
Reporting Date
Jun 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.96%
 
 
 
 
 
 
Growthannually 41.20%
 
 
 
 

Sales

Growthquarterly 434.17%
 
 
 
 
 
Growthannually 779.36%
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account